Walter BloombergFinance

UBS SEES GLP-1 DRUGS WEIGHING ON RESTAURANTS UBS says growing use of GLP-1 weight-loss drugs could become a headwind for restaurant sales a…

UBS SEES GLP-1 DRUGS WEIGHING ON RESTAURANTS UBS says growing use of GLP-1 weight-loss drugs could become a headwind for restaurant sales as users cut calories, dine out less, and shift toward healthier foods. The bank expects restaurants to increasingly adapt menus with smaller portions and healthier options, with fast food and less healthy chains most at risk.
SHOW ON TELEGRAM

More from Walter Bloomberg